A carregar...
US Payer Perspectives on Evidence for Formulary Decision Making
PURPOSE: The perspective of commercial payers on comparative effectiveness research (CER) has not been well researched. This study aims to describe how US commercial payers use and value CER for formulary decision making in different disease states. METHODS: We recruited 20 medical and pharmaceutica...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Clinical Oncology
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3348603/ https://ncbi.nlm.nih.gov/pubmed/22942820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000526 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|